Tio Shio Yen, Chen Sharon C A, Heath Christopher H, Pradhan Alyssa, Morris Arthur J, Korman Tony M, Morrissey C Orla, Halliday Catriona L, Kidd Sarah, Spelman Timothy, Brell Nadiya, McMullan Brendan, Clark Julia E, Mitsakos Katerina, Hardiman Robyn P, Williams Phoebe C M, Campbell Anita J, Beardsley Justin, Van Hal Sebastiaan, Yong Michelle K, Worth Leon J, Slavin Monica A
Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia.
National Centre for Infections in Cancer, Melbourne, Australia.
Open Forum Infect Dis. 2024 Oct 9;11(11):ofae594. doi: 10.1093/ofid/ofae594. eCollection 2024 Nov.
International consensus definitions for invasive aspergillosis (IA) in research are rigorous, yet clinically significant cases are often excluded from clinical studies for not meeting proven/probable IA case definitions. To better understand reasons for the failure to meet criteria for proven/probable infection, we herein review 47 such cases for their clinical and microbiological characteristics and outcomes.
Data on 47 cases that did not meet consensus IA definitions but were deemed significant were derived from a retrospective, observational, multicenter survey of 382 presumed IA cases across Australasia, of which findings of 221 proven/probable infections were recently published. The clinical, microbiological, and radiologic characteristics of these cases were analyzed. Mortality outcomes were compared with those of 221 proven/probable cases.
Of 47 cases studied, 15 lacked classical host factors; 22 exhibited only a single positive polymerase chain reaction result; 7 lacked typical IA radiologic findings on chest computed tomography; and 3 had borderline galactomannan optical density indices (<1.0 but ≥0.5) in bronchoalveolar lavage fluid. The median age of patients was 61 years (IQR, 52-68); 34 were male (72%). Seven patients (15%) required intensive care admission. All patients had lung as the primary site of infection. Antifungal treatment was initiated in 42 patients (89%). All-cause 90-day mortality was 33%, similar to the 30% mortality in the comparative cohort (n = 221).
Our findings highlight the limitations of current consensus definitions for IA. Notably, the mortality of patients not meeting these definitions was similar to that of patients with proven/probable IA. Further studies, especially of patients with a single positive polymerase chain reaction result and those without host factors, are needed to determine if future consensus definitions may benefit from modifications.
研究中侵袭性曲霉病(IA)的国际共识定义较为严格,但临床上的重要病例常因不符合确诊/疑似IA病例定义而被排除在临床研究之外。为了更好地理解未能达到确诊/疑似感染标准的原因,我们在此回顾47例此类病例的临床、微生物学特征及转归。
47例未符合IA共识定义但被认为具有重要意义的病例数据,来源于对澳大拉西亚地区382例疑似IA病例的一项回顾性、观察性、多中心调查,其中221例确诊/疑似感染的研究结果近期已发表。对这些病例的临床、微生物学和放射学特征进行了分析。将死亡转归与221例确诊/疑似病例的转归进行比较。
在研究的47例病例中,15例缺乏典型的宿主因素;22例仅表现出一次聚合酶链反应阳性结果;7例胸部计算机断层扫描未显示典型的IA影像学表现;3例支气管肺泡灌洗液中的半乳甘露聚糖光密度指数处于临界值(<1.0但≥0.5)。患者的中位年龄为61岁(四分位间距,52 - 68岁);34例为男性(72%)。7例患者(15%)需要入住重症监护病房。所有患者均以肺部作为主要感染部位。42例患者(89%)开始了抗真菌治疗。90天全因死亡率为33%,与对照队列(n = 221)中的30%死亡率相似。
我们的研究结果突出了当前IA共识定义的局限性。值得注意的是,未符合这些定义的患者死亡率与确诊/疑似IA患者的死亡率相似。需要进一步研究,尤其是对仅有一次聚合酶链反应阳性结果的患者以及无宿主因素的患者进行研究,以确定未来的共识定义是否可能受益于修改。